Samsung Bioepis and Organon Announce FDA Approval of Citrate-Free High-Concentration HUMIRA® Biosimilar HADLIMA™ (adalimumab-bwwd)
INCHEON, Korea & JERSEY CITY, N.J.--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. and Organon & Co. (NYSE:…
INCHEON, Korea & JERSEY CITY, N.J.--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. and Organon & Co. (NYSE:…
Using Fluree’s blockchain-based database technology, Sinisana offers business customers and consumers 100% transparency into the…
Industry Suppliers and Buyers to gather from 14-16 September 2022 for networking, sourcing and learning…
Activity related to the Russian invasion of Ukraine causes shifts in the threat landscape Patriotic…
Activity related to the Russian invasion of Ukraine causes shifts in the threat landscape Patriotic…
Myleeta assumes Office in August to accelerate the brand's international footprint and support expansion plans…
Myleeta assumes Office in August to accelerate the brand's international footprint and support expansion plans…
Revenue Up by 17.2% and Adjusted Net Profit Margin1 Improved by 17.3ppt YoY for Second…
10th generation MiFi® brand mobile hotspot offers expanded 5G and enterprise-specific features SAN DIEGO &…
KUALA LUMPUR, MALAYSIA - Media OutReach - 17 August 2022 - Most Malaysian businesses are…